Hilmar Lapp is part of an interdisciplinary, multi-institutional collaboration led by Ohio State that will establish a new field of study called “imageomics” that has the potential to transform bio
Xilis, Inc., a pioneering company developing its MicroOrganoSphereTM (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, announced to
A CRISPR-Cas9 variant with deactivated DNA-cutting function is a powerful tool to help researchers understand what genes do when their expression is dialed up or down, but it has some limitations.